Croda International Plc (LON:CRDA – Get Free Report) insider Tom Brophy acquired 5 shares of the business’s stock in a transaction dated Monday, October 12th. The stock was purchased at an average price of GBX 3,388 per share, with a total value of £169.40.
Tom Brophy also recently made the following trade(s):
- On Monday, August 10th, Tom Brophy bought 5 shares of Croda International stock. The shares were purchased at an average cost of GBX 3,292 per share, with a total value of £164.60.
Croda International Price Performance
LON:CRDA traded up GBX 100 during mid-day trading on Tuesday, reaching GBX 3,517. 463,121 shares of the stock were exchanged, compared to its average volume of 4,424,601. The business has a fifty day moving average price of GBX 3,295.78 and a 200 day moving average price of GBX 3,075.73. The firm has a market capitalization of £4.90 billion, a PE ratio of 61.81, a PEG ratio of 1.40 and a beta of 0.92. Croda International Plc has a 1-year low of GBX 2,488 and a 1-year high of GBX 3,543. The company has a current ratio of 2.57, a quick ratio of 2.25 and a debt-to-equity ratio of 36.06.
Wall Street Analyst Weigh In
A number of analysts recently commented on CRDA shares. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 4,000 target price on shares of Croda International in a report on Friday, September 25th. Citigroup raised their target price on shares of Croda International from GBX 3,050 to GBX 3,200 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a GBX 3,300 price target on shares of Croda International in a research report on Wednesday, July 29th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 3,600 price target on shares of Croda International in a report on Wednesday, July 29th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Croda International currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 3,490.
Check Out Our Latest Stock Report on Croda International
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Further Reading
- Five stocks we like better than Croda International
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
- JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
